i2o Therapeutics

Biotechnology, Health Care, Therapeutics
Founded in 1/1/19
Allston, Massachusetts, United States
http://www.i2obio.com/
For Profit

About i2o Therapeutics

i2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies traditionally limited to injections. Using an innovative ionic liquid technology, it leverages the benefits of protecting the drug cargo while also transiently enhancing permeation across the epithelial lining when administered orally. i2o is focused on creating the next generation of oral peptide and protein-based therapies. The company was founded in 2019 and based in Saratoga, California.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: 496
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 44439921 USD
  • Last Funding: 33539921 USD (Venture - Series Unknown)
  • Funding Status:

Technology Stack

i2o Therapeutics actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Therapeutics

Headquarters: Allston, Massachusetts, United States

Employees